FDA-registered analytical lab · Research Triangle Park, NC

+1 (919) 704-5617contact@smabiolabs.com

Your Strategic CDMO Partner — From Molecule to Market

From early-stage discovery through product and process development, analytical services, and commercialization readiness, SmaBio Labs provides integrated scientific support with regulatory precision.

One Partner. One Strategy. End-to-End Development.

  • FDA-registered lab*
  • U.S.-based operations
  • Successful client audits
  • cGMP CTM Phase I–II
  • ICH-compliant stability
*Analytical Lab

Specialties

Specialties index

Analytical Services

Comprehensive analytical development and validation supporting regulatory submissions, product release, and long-term lifecycle management.

IND NDA 510(k) BLA ANDA

Small Molecules

  • Method Development and Validation
  • ICH Stability and Release Testing
  • Material Characterization
  • Impurity Identification and Testing
  • Extractables and Leachables (E&L)
  • Nitrosamine Testing
  • Elemental Impurities
  • HPAPI and Sterile Product Support

Large Molecules

  • ADC Testing
  • Protein & Polypeptide Testing

Small Molecules →Biologics →

Product Development

Strategic formulation and CMC development designed to advance APIs into stable dosage forms ready for clinical development.

IND NDA ANDA 505(b)(2) QbD
  • Pre-Formulation Studies
  • Formulation Development (QbD Driven Approach)
  • Process Development
  • Preclinical and Clinical Trial Material Manufacturing
  • Clinical Packaging and Labeling
  • HPAPI Formulation and Potent API handling

Product Development →

Drug Discovery & Process Development

Integrated discovery and process chemistry designed to deliver scalable, efficient routes from early research through API scale-up.

Type II · III DMF ICH Q3A / Q3B ICH Q1 cGMP Phase I–III API
  • Early-Stage Scientific Support
  • mg–g Scale API and Intermediate Production
  • kg-Scale API Manufacturing
  • DMF Filing & Regulatory Support

Drug Discovery & Process Development →

Stability Storage & Testing

ICH-compliant stability storage and analytical testing supporting clinical development and global regulatory submissions.

ICH Q1 Zones I–IVb to −80 °C
  • ICH Stability and Release Testing
  • Stability Storage Conditions (ICH-Compliant)
  • Stability programs for small molecules, peptides, biologics, and medical devices

Stability Storage & Testing →

CTM Manufacturing

GMP-compliant clinical trial material manufacturing supporting early-phase studies and regulatory submissions.

cGMP Phase I–II 21 CFR ISO 7/8 ISO 5 BSC
  • Sterile Manufacturing Capabilities
  • CTM Manufacturing for Non-sterile Products
  • Preclinical → Phase I → Phase II

CTM Manufacturing →

Custom Synthesis

Flexible synthesis support for API intermediates, reference standards and impurities.

  • API intermediates
  • Reference standards
  • Impurities

Start a Project →

Development pathway

QbD-Driven Product Development Pathway for Regulatory Alignment

From pre-formulation to launch, SmaBio Labs develops robust, compliant, patient-focused pharmaceutical solutions designed for successful development and scale-up.

More Details →
  1. Step 01

    Pre-Formulation

    Defining Product and Material Attributes to Guide Formulation and Development Strategies.

  2. Step 02

    Formulation Development

    Developing Robust Formulations to Support Product Performance, Quality, and Manufacturability.

  3. Step 03

    Process Development

    Designing Robust Manufacturing Processes to Support Consistent Product Quality and Scale-up.

  4. Step 04

    Scale-Up and Stability

    Confirming Product Robustness Through Scale-Up and Stability Studies.

Contact Us

Start your journey, explore SmaBio Labs

Connect with our team of expert scientists

Tell us about your molecule, your milestones and your timeline.

Address
104 T.W. Alexander Drive, Building 18, Durham, NC 27713, United States
Contact form* Required

Most partners hear back within one business day.